No Picture
News

Biopharma companies pledge $1B to fund antibiotics R&D as field shrivels; Four biotechs hunt $797M+

? As promised, a group of some 20 biopharma companies have pooled close to $1 billion to fund new research in antibiotics — a field that has been dying of late. Small margins and tiny markets have killed off a slate of players in the field and drove ou… […]

No Picture
Events

LaunchBio Big Pitch 2020 : Jul 23, 2020

The Big Pitch is a virtual quick pitch competition for the most promising biotech startups in the US. This summer series challenges all-stars from Cambridge, San Diego, and Durham to score points with investor judges. The winning startup from each regi… […]

No Picture
News

Zai Lab inks China deal with Turning Point with $25M upfront; Xencor, Atreca team up on bispecifics

? Zai Lab is paying out a $25 million upfront for the rights to sell Turning Point Therapeutics’ lead drug repotrectinib in Greater China. The San Diego-based biotech is also in line for up to $151 million in milestones, along with mid-to-high teen roy… […]

No Picture
News

CEND Therapeutics Announces Board Member David Slack Will Succeed Erkki Ruoshlahti as President & CEO

LA JOLLA, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Cend Therapeutics, Inc. (formerly DrugCendR, Inc.), a clinical-stage biotech company, announced today changes in the senior management of the company. David Slack, MBA will take over as President an… […]

No Picture
News

Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the TruSight™ Software Suite. TruSight Software delivers read… […]

No Picture
News

Heritage Global Patents & Trademarks to Conduct Global Sealed-Bid Auction of Cancer Therapeutic Patent Portfolio

Therapies for the Treatment of Tumor, Autoimmune Diseases and Other DiseasesBid Submission Deadline – July 16, 2020 – 5pm PDTAffigen’s Patent Portfolio will be sold to the highest Bidder. No Minimum Bid! Bids of Any Amount are Welcome

SAN DIEGO, July… […]

No Picture
News

BlueNalu Signs MOU with Pulmuone, Announces Partnership Bringing Cell-Based Seafood to South Korea

SAN DIEGO–(BUSINESS WIRE)–BlueNalu, a leading food technology company developing cell-based seafood products, announced today the signing of a Memorandum of Understanding (MOU) with Pulmuone Co. Ltd., a leader in healthy lifestyle and environmentally… […]

No Picture
News

Salk scientists discover genetic “dial” to turn immune function up and down to target cancer, autoimmune disease

LA JOLLA—The human immune system is a finely-tuned machine, balancing when to release a cellular army to deal with pathogens, with when to rein in that army, stopping an onslaught from attacking the body itself. Now, Salk researchers have discovered a … […]

No Picture
News

Qualigen Therapeutics Engages NFL Hall of Famer Mike Haynes as Advisor to the Company and Spokesman for the FastPack® Rapid Diagnostic System “Which Saved My Life”

CARLSBAD, Calif., July 7, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company”) announces it has engaged Pro Football Hall of Fame and College Football Hall of Fame inductee Mike Haynes as an advisor to the Co… […]

No Picture
News

Lineage Cell Therapeutics Announces Extension of OpRegen® Development Grant From Israel Innovation Authority

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced that as a result of contin… […]

No Picture
News

Women Who Mean Business

UC San Diego is proud to have been named a top 25 undergraduate university for female-founded startups by Pitchbook, a financial data and software company. UC San Diego landed in the No. 22 spot with 45 female f… […]